Cargando…
BRENDA-Score, a Highly Significant, Internally and Externally Validated Prognostic Marker for Metastatic Recurrence: Analysis of 10,449 Primary Breast Cancer Patients
SIMPLE SUMMARY: The BRENDA-Score provides an easy to use tool for clinicians to estimate the risk of recurrence in primary breast cancer. The algorithm has been validated via a second independent database and provides five recurrence risk groups. This grouping helps clinicians to encourage high risk...
Autores principales: | Wischnewsky, Manfred, Schwentner, Lukas, Diessner, Joachim, de Gregorio, Amelie, Joukhadar, Ralf, Davut, Dayan, Salmen, Jessica, Bekes, Inga, Kiesel, Matthias, Müller-Reiter, Max, Blettner, Maria, Wolters, Regine, Janni, Wolfgang, Kreienberg, Rolf, Wöckel, Achim, Ebner, Florian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268855/ https://www.ncbi.nlm.nih.gov/pubmed/34206581 http://dx.doi.org/10.3390/cancers13133121 |
Ejemplares similares
-
Implications for surveillance for breast cancer patients based on the internally and externally validated BRENDA-metastatic recurrence score
por: Ebner, Florian, et al.
Publicado: (2023) -
Does the number of removed axillary lymphnodes in high risk breast cancer patients influence the survival?
por: Ebner, Florian, et al.
Publicado: (2019) -
Outcome analysis of primary breast cancer patients who declined adjuvant chemotherapy—results from the prospective multi-center BRENDA II study
por: Leinert, Elena, et al.
Publicado: (2022) -
Do Patients with Luminal A Breast Cancer Profit from Adjuvant Systemic Therapy? A Retrospective Multicenter Study
por: Diessner, Joachim, et al.
Publicado: (2016) -
Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer
por: Diessner, Joachim, et al.
Publicado: (2016)